Endostim, Inc. IPO Research Information

Endostim, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Endostim, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Endostim, Inc.	STIM - NASDAQ	TBD	$0.00	$0.00	3.2 million
Underwriter(s): Wedbush PacGrow Life Sciences
Co-Manager(s): Craig-Hallum Capital Group, Roth Capital Partners
Industry: Health Care
Filing(s): Filed 2014-09-05 Terms Added 2014-09-30

About Endostim, Inc. (adapted from Endostim, Inc. prospectus):
They are a medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD.

This description is adapted from Endostim prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Endostim "STIM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.